Production of full-length SARS-CoV-2 nucleocapsid protein from Escherichia coli optimized by native hydrophobic interaction chromatography hyphenated to multi-angle light scattering detection
The nucleocapsid protein (NP) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for several steps of the viral life cycle, and is abundantly expressed during infection, making it an ideal diagnostic target protein. This protein has a strong tendency for dimerization and int...
Gespeichert in:
Veröffentlicht in: | Talanta (Oxford) 2021-12, Vol.235, p.122691-122691, Article 122691 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 122691 |
---|---|
container_issue | |
container_start_page | 122691 |
container_title | Talanta (Oxford) |
container_volume | 235 |
creator | De Vos, Jelle Pereira Aguilar, Patricia Köppl, Christoph Fischer, Andreas Grünwald-Gruber, Clemens Dürkop, Mark Klausberger, Miriam Mairhofer, Juergen Striedner, Gerald Cserjan-Puschmann, Monika Jungbauer, Alois Lingg, Nico |
description | The nucleocapsid protein (NP) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for several steps of the viral life cycle, and is abundantly expressed during infection, making it an ideal diagnostic target protein. This protein has a strong tendency for dimerization and interaction with nucleic acids. For the first time, high titers of NP were expressed in E. coli with a CASPON tag, using a growth-decoupled protein expression system. Purification was accomplished by nuclease treatment of the cell homogenate and a sequence of downstream processing (DSP) steps. An analytical method consisting of native hydrophobic interaction chromatography hyphenated to multi-angle light scattering detection (HIC-MALS) was established for in-process control, in particular, to monitor product fragmentation and multimerization throughout the purification process. 730 mg purified NP per liter of fermentation could be produced by the optimized process, corresponding to a yield of 77% after cell lysis. The HIC-MALS method was used to demonstrate that the NP product can be produced with a purity of 95%. The molecular mass of the main NP fraction is consistent with dimerized protein as was verified by a complementary native size-exclusion separation (SEC)-MALS analysis. Peptide mapping mass spectrometry and host cell specific enzyme-linked immunosorbent assay confirmed the high product purity, and the presence of a minor endogenous chaperone explained the residual impurities. The optimized HIC-MALS method enables monitoring of the product purity, and simultaneously access its molecular mass, providing orthogonal information complementary to established SEC-MALS methods. Enhanced resolving power can be achieved over SEC, attributed to the extended variables to tune selectivity in HIC mode.
[Display omitted]
•Nucleocapsid was produced in high titers using a growth-decoupled expression system.•CASPON tag technology was utilized to enable high cleavage specificity.•A novel analytical HIC-MALS method was developed for quality control.•An optimized downstream processing set-up provides 95% product purity. |
doi_str_mv | 10.1016/j.talanta.2021.122691 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8284068</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0039914021006123</els_id><sourcerecordid>2572530460</sourcerecordid><originalsourceid>FETCH-LOGICAL-c467t-94e59fd46f410fca2bf8729e53c619ec732a91830b636b08f454c947be7ac4773</originalsourceid><addsrcrecordid>eNqFkcmO1DAQhiMEYpqBRwD5yCWNt8TJBTRqDYs0EogBrpbjVBK3HDvYTkvNy_FqeOhmBCdOdah_KdVXFM8J3hJM6lf7bVJWuaS2FFOyJZTWLXlQbEgjWMkqwR4WG4xZW7aE44viSYx7jDFlmD0uLhiviKiE2BQ_PwXfrzoZ75Af0LBaW1pwY5rQ7dXn23Lnv5UUuVVb8Fot0fRoCT6BcWgIfkbXUU8QjJ6MQtpbg_ySzGx-QI-6I3IqmQOg6dgHv0y-MxoZlyCoU6GecoRKfgxqmY5ZtkyQLdmbPJpXm0yp3GgBWTNOCUWtUjYbN6IeEvzOeFo8GpSN8Ow8L4uvb6-_7N6XNx_ffdhd3ZSa1yKVLYeqHXpeD5zgQSvaDY2gLVRM16QFLRhVLWkY7mpWd7gZeMV1y0UHQmkuBLssXp9yl7WbodfgUlBWLsHMKhylV0b-u3FmkqM_yIY2HNdNDnh5Dgj--woxydlEDTYzBL9GSStBK4Z5jbO0Okl18DEGGO5rCJZ38OVenuHLO_jyBD_7Xvx9473rD-0seHMSQP7UwUCQURtwGnoT8jtl781_Kn4BuD_Jyg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2572530460</pqid></control><display><type>article</type><title>Production of full-length SARS-CoV-2 nucleocapsid protein from Escherichia coli optimized by native hydrophobic interaction chromatography hyphenated to multi-angle light scattering detection</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>De Vos, Jelle ; Pereira Aguilar, Patricia ; Köppl, Christoph ; Fischer, Andreas ; Grünwald-Gruber, Clemens ; Dürkop, Mark ; Klausberger, Miriam ; Mairhofer, Juergen ; Striedner, Gerald ; Cserjan-Puschmann, Monika ; Jungbauer, Alois ; Lingg, Nico</creator><creatorcontrib>De Vos, Jelle ; Pereira Aguilar, Patricia ; Köppl, Christoph ; Fischer, Andreas ; Grünwald-Gruber, Clemens ; Dürkop, Mark ; Klausberger, Miriam ; Mairhofer, Juergen ; Striedner, Gerald ; Cserjan-Puschmann, Monika ; Jungbauer, Alois ; Lingg, Nico</creatorcontrib><description>The nucleocapsid protein (NP) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for several steps of the viral life cycle, and is abundantly expressed during infection, making it an ideal diagnostic target protein. This protein has a strong tendency for dimerization and interaction with nucleic acids. For the first time, high titers of NP were expressed in E. coli with a CASPON tag, using a growth-decoupled protein expression system. Purification was accomplished by nuclease treatment of the cell homogenate and a sequence of downstream processing (DSP) steps. An analytical method consisting of native hydrophobic interaction chromatography hyphenated to multi-angle light scattering detection (HIC-MALS) was established for in-process control, in particular, to monitor product fragmentation and multimerization throughout the purification process. 730 mg purified NP per liter of fermentation could be produced by the optimized process, corresponding to a yield of 77% after cell lysis. The HIC-MALS method was used to demonstrate that the NP product can be produced with a purity of 95%. The molecular mass of the main NP fraction is consistent with dimerized protein as was verified by a complementary native size-exclusion separation (SEC)-MALS analysis. Peptide mapping mass spectrometry and host cell specific enzyme-linked immunosorbent assay confirmed the high product purity, and the presence of a minor endogenous chaperone explained the residual impurities. The optimized HIC-MALS method enables monitoring of the product purity, and simultaneously access its molecular mass, providing orthogonal information complementary to established SEC-MALS methods. Enhanced resolving power can be achieved over SEC, attributed to the extended variables to tune selectivity in HIC mode.
[Display omitted]
•Nucleocapsid was produced in high titers using a growth-decoupled expression system.•CASPON tag technology was utilized to enable high cleavage specificity.•A novel analytical HIC-MALS method was developed for quality control.•An optimized downstream processing set-up provides 95% product purity.</description><identifier>ISSN: 0039-9140</identifier><identifier>EISSN: 1873-3573</identifier><identifier>DOI: 10.1016/j.talanta.2021.122691</identifier><identifier>PMID: 34517577</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Chromatography ; COVID-19 ; cpCasp2‐based platform fusion protein process (CASPON technology) ; Downstream processing (DSP) ; Escherichia coli - genetics ; Humans ; Hydrophobic and Hydrophilic Interactions ; Hydrophobic interaction chromatography-multi-angle light scattering (HIC-MALS) ; Novel coronavirus (termed SARS-CoV-2) ; Nucleocapsid Proteins - genetics ; Nucleoprotein ; SARS-CoV-2</subject><ispartof>Talanta (Oxford), 2021-12, Vol.235, p.122691-122691, Article 122691</ispartof><rights>2021 The Authors</rights><rights>Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.</rights><rights>2021 The Authors 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c467t-94e59fd46f410fca2bf8729e53c619ec732a91830b636b08f454c947be7ac4773</citedby><cites>FETCH-LOGICAL-c467t-94e59fd46f410fca2bf8729e53c619ec732a91830b636b08f454c947be7ac4773</cites><orcidid>0000-0003-3346-4832 ; 0000-0001-8182-7728 ; 0000-0002-3574-6991 ; 0000-0001-7880-9916 ; 0000-0002-9811-9709 ; 0000-0001-7653-1498</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.talanta.2021.122691$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34517577$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>De Vos, Jelle</creatorcontrib><creatorcontrib>Pereira Aguilar, Patricia</creatorcontrib><creatorcontrib>Köppl, Christoph</creatorcontrib><creatorcontrib>Fischer, Andreas</creatorcontrib><creatorcontrib>Grünwald-Gruber, Clemens</creatorcontrib><creatorcontrib>Dürkop, Mark</creatorcontrib><creatorcontrib>Klausberger, Miriam</creatorcontrib><creatorcontrib>Mairhofer, Juergen</creatorcontrib><creatorcontrib>Striedner, Gerald</creatorcontrib><creatorcontrib>Cserjan-Puschmann, Monika</creatorcontrib><creatorcontrib>Jungbauer, Alois</creatorcontrib><creatorcontrib>Lingg, Nico</creatorcontrib><title>Production of full-length SARS-CoV-2 nucleocapsid protein from Escherichia coli optimized by native hydrophobic interaction chromatography hyphenated to multi-angle light scattering detection</title><title>Talanta (Oxford)</title><addtitle>Talanta</addtitle><description>The nucleocapsid protein (NP) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for several steps of the viral life cycle, and is abundantly expressed during infection, making it an ideal diagnostic target protein. This protein has a strong tendency for dimerization and interaction with nucleic acids. For the first time, high titers of NP were expressed in E. coli with a CASPON tag, using a growth-decoupled protein expression system. Purification was accomplished by nuclease treatment of the cell homogenate and a sequence of downstream processing (DSP) steps. An analytical method consisting of native hydrophobic interaction chromatography hyphenated to multi-angle light scattering detection (HIC-MALS) was established for in-process control, in particular, to monitor product fragmentation and multimerization throughout the purification process. 730 mg purified NP per liter of fermentation could be produced by the optimized process, corresponding to a yield of 77% after cell lysis. The HIC-MALS method was used to demonstrate that the NP product can be produced with a purity of 95%. The molecular mass of the main NP fraction is consistent with dimerized protein as was verified by a complementary native size-exclusion separation (SEC)-MALS analysis. Peptide mapping mass spectrometry and host cell specific enzyme-linked immunosorbent assay confirmed the high product purity, and the presence of a minor endogenous chaperone explained the residual impurities. The optimized HIC-MALS method enables monitoring of the product purity, and simultaneously access its molecular mass, providing orthogonal information complementary to established SEC-MALS methods. Enhanced resolving power can be achieved over SEC, attributed to the extended variables to tune selectivity in HIC mode.
[Display omitted]
•Nucleocapsid was produced in high titers using a growth-decoupled expression system.•CASPON tag technology was utilized to enable high cleavage specificity.•A novel analytical HIC-MALS method was developed for quality control.•An optimized downstream processing set-up provides 95% product purity.</description><subject>Chromatography</subject><subject>COVID-19</subject><subject>cpCasp2‐based platform fusion protein process (CASPON technology)</subject><subject>Downstream processing (DSP)</subject><subject>Escherichia coli - genetics</subject><subject>Humans</subject><subject>Hydrophobic and Hydrophilic Interactions</subject><subject>Hydrophobic interaction chromatography-multi-angle light scattering (HIC-MALS)</subject><subject>Novel coronavirus (termed SARS-CoV-2)</subject><subject>Nucleocapsid Proteins - genetics</subject><subject>Nucleoprotein</subject><subject>SARS-CoV-2</subject><issn>0039-9140</issn><issn>1873-3573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcmO1DAQhiMEYpqBRwD5yCWNt8TJBTRqDYs0EogBrpbjVBK3HDvYTkvNy_FqeOhmBCdOdah_KdVXFM8J3hJM6lf7bVJWuaS2FFOyJZTWLXlQbEgjWMkqwR4WG4xZW7aE44viSYx7jDFlmD0uLhiviKiE2BQ_PwXfrzoZ75Af0LBaW1pwY5rQ7dXn23Lnv5UUuVVb8Fot0fRoCT6BcWgIfkbXUU8QjJ6MQtpbg_ySzGx-QI-6I3IqmQOg6dgHv0y-MxoZlyCoU6GecoRKfgxqmY5ZtkyQLdmbPJpXm0yp3GgBWTNOCUWtUjYbN6IeEvzOeFo8GpSN8Ow8L4uvb6-_7N6XNx_ffdhd3ZSa1yKVLYeqHXpeD5zgQSvaDY2gLVRM16QFLRhVLWkY7mpWd7gZeMV1y0UHQmkuBLssXp9yl7WbodfgUlBWLsHMKhylV0b-u3FmkqM_yIY2HNdNDnh5Dgj--woxydlEDTYzBL9GSStBK4Z5jbO0Okl18DEGGO5rCJZ38OVenuHLO_jyBD_7Xvx9473rD-0seHMSQP7UwUCQURtwGnoT8jtl781_Kn4BuD_Jyg</recordid><startdate>20211201</startdate><enddate>20211201</enddate><creator>De Vos, Jelle</creator><creator>Pereira Aguilar, Patricia</creator><creator>Köppl, Christoph</creator><creator>Fischer, Andreas</creator><creator>Grünwald-Gruber, Clemens</creator><creator>Dürkop, Mark</creator><creator>Klausberger, Miriam</creator><creator>Mairhofer, Juergen</creator><creator>Striedner, Gerald</creator><creator>Cserjan-Puschmann, Monika</creator><creator>Jungbauer, Alois</creator><creator>Lingg, Nico</creator><general>Elsevier B.V</general><general>The Authors. Published by Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3346-4832</orcidid><orcidid>https://orcid.org/0000-0001-8182-7728</orcidid><orcidid>https://orcid.org/0000-0002-3574-6991</orcidid><orcidid>https://orcid.org/0000-0001-7880-9916</orcidid><orcidid>https://orcid.org/0000-0002-9811-9709</orcidid><orcidid>https://orcid.org/0000-0001-7653-1498</orcidid></search><sort><creationdate>20211201</creationdate><title>Production of full-length SARS-CoV-2 nucleocapsid protein from Escherichia coli optimized by native hydrophobic interaction chromatography hyphenated to multi-angle light scattering detection</title><author>De Vos, Jelle ; Pereira Aguilar, Patricia ; Köppl, Christoph ; Fischer, Andreas ; Grünwald-Gruber, Clemens ; Dürkop, Mark ; Klausberger, Miriam ; Mairhofer, Juergen ; Striedner, Gerald ; Cserjan-Puschmann, Monika ; Jungbauer, Alois ; Lingg, Nico</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c467t-94e59fd46f410fca2bf8729e53c619ec732a91830b636b08f454c947be7ac4773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Chromatography</topic><topic>COVID-19</topic><topic>cpCasp2‐based platform fusion protein process (CASPON technology)</topic><topic>Downstream processing (DSP)</topic><topic>Escherichia coli - genetics</topic><topic>Humans</topic><topic>Hydrophobic and Hydrophilic Interactions</topic><topic>Hydrophobic interaction chromatography-multi-angle light scattering (HIC-MALS)</topic><topic>Novel coronavirus (termed SARS-CoV-2)</topic><topic>Nucleocapsid Proteins - genetics</topic><topic>Nucleoprotein</topic><topic>SARS-CoV-2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>De Vos, Jelle</creatorcontrib><creatorcontrib>Pereira Aguilar, Patricia</creatorcontrib><creatorcontrib>Köppl, Christoph</creatorcontrib><creatorcontrib>Fischer, Andreas</creatorcontrib><creatorcontrib>Grünwald-Gruber, Clemens</creatorcontrib><creatorcontrib>Dürkop, Mark</creatorcontrib><creatorcontrib>Klausberger, Miriam</creatorcontrib><creatorcontrib>Mairhofer, Juergen</creatorcontrib><creatorcontrib>Striedner, Gerald</creatorcontrib><creatorcontrib>Cserjan-Puschmann, Monika</creatorcontrib><creatorcontrib>Jungbauer, Alois</creatorcontrib><creatorcontrib>Lingg, Nico</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Talanta (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>De Vos, Jelle</au><au>Pereira Aguilar, Patricia</au><au>Köppl, Christoph</au><au>Fischer, Andreas</au><au>Grünwald-Gruber, Clemens</au><au>Dürkop, Mark</au><au>Klausberger, Miriam</au><au>Mairhofer, Juergen</au><au>Striedner, Gerald</au><au>Cserjan-Puschmann, Monika</au><au>Jungbauer, Alois</au><au>Lingg, Nico</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Production of full-length SARS-CoV-2 nucleocapsid protein from Escherichia coli optimized by native hydrophobic interaction chromatography hyphenated to multi-angle light scattering detection</atitle><jtitle>Talanta (Oxford)</jtitle><addtitle>Talanta</addtitle><date>2021-12-01</date><risdate>2021</risdate><volume>235</volume><spage>122691</spage><epage>122691</epage><pages>122691-122691</pages><artnum>122691</artnum><issn>0039-9140</issn><eissn>1873-3573</eissn><abstract>The nucleocapsid protein (NP) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical for several steps of the viral life cycle, and is abundantly expressed during infection, making it an ideal diagnostic target protein. This protein has a strong tendency for dimerization and interaction with nucleic acids. For the first time, high titers of NP were expressed in E. coli with a CASPON tag, using a growth-decoupled protein expression system. Purification was accomplished by nuclease treatment of the cell homogenate and a sequence of downstream processing (DSP) steps. An analytical method consisting of native hydrophobic interaction chromatography hyphenated to multi-angle light scattering detection (HIC-MALS) was established for in-process control, in particular, to monitor product fragmentation and multimerization throughout the purification process. 730 mg purified NP per liter of fermentation could be produced by the optimized process, corresponding to a yield of 77% after cell lysis. The HIC-MALS method was used to demonstrate that the NP product can be produced with a purity of 95%. The molecular mass of the main NP fraction is consistent with dimerized protein as was verified by a complementary native size-exclusion separation (SEC)-MALS analysis. Peptide mapping mass spectrometry and host cell specific enzyme-linked immunosorbent assay confirmed the high product purity, and the presence of a minor endogenous chaperone explained the residual impurities. The optimized HIC-MALS method enables monitoring of the product purity, and simultaneously access its molecular mass, providing orthogonal information complementary to established SEC-MALS methods. Enhanced resolving power can be achieved over SEC, attributed to the extended variables to tune selectivity in HIC mode.
[Display omitted]
•Nucleocapsid was produced in high titers using a growth-decoupled expression system.•CASPON tag technology was utilized to enable high cleavage specificity.•A novel analytical HIC-MALS method was developed for quality control.•An optimized downstream processing set-up provides 95% product purity.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>34517577</pmid><doi>10.1016/j.talanta.2021.122691</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-3346-4832</orcidid><orcidid>https://orcid.org/0000-0001-8182-7728</orcidid><orcidid>https://orcid.org/0000-0002-3574-6991</orcidid><orcidid>https://orcid.org/0000-0001-7880-9916</orcidid><orcidid>https://orcid.org/0000-0002-9811-9709</orcidid><orcidid>https://orcid.org/0000-0001-7653-1498</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0039-9140 |
ispartof | Talanta (Oxford), 2021-12, Vol.235, p.122691-122691, Article 122691 |
issn | 0039-9140 1873-3573 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8284068 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Chromatography COVID-19 cpCasp2‐based platform fusion protein process (CASPON technology) Downstream processing (DSP) Escherichia coli - genetics Humans Hydrophobic and Hydrophilic Interactions Hydrophobic interaction chromatography-multi-angle light scattering (HIC-MALS) Novel coronavirus (termed SARS-CoV-2) Nucleocapsid Proteins - genetics Nucleoprotein SARS-CoV-2 |
title | Production of full-length SARS-CoV-2 nucleocapsid protein from Escherichia coli optimized by native hydrophobic interaction chromatography hyphenated to multi-angle light scattering detection |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T08%3A11%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Production%20of%20full-length%20SARS-CoV-2%20nucleocapsid%20protein%20from%20Escherichia%20coli%20optimized%20by%20native%20hydrophobic%20interaction%20chromatography%20hyphenated%20to%20multi-angle%20light%20scattering%20detection&rft.jtitle=Talanta%20(Oxford)&rft.au=De%20Vos,%20Jelle&rft.date=2021-12-01&rft.volume=235&rft.spage=122691&rft.epage=122691&rft.pages=122691-122691&rft.artnum=122691&rft.issn=0039-9140&rft.eissn=1873-3573&rft_id=info:doi/10.1016/j.talanta.2021.122691&rft_dat=%3Cproquest_pubme%3E2572530460%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2572530460&rft_id=info:pmid/34517577&rft_els_id=S0039914021006123&rfr_iscdi=true |